Clinical Trial Update: A Study to Assess the Efficacy and Safety of HMI-115 in Subjects With Endometriosis-Associated Pain [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of HMI-115 for endometriosis-associated pain has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• HMI-115

Snippet

Sponsor: Hope Medicine (Nanjing) Co., Ltd | Conditions: Endometriosis | Phase 2 | Status: COMPLETED | Results posted: 2025-11-18